Previous studies have identified cluster of differentiation 44 (CD44) and aldehyde dehydrogenase (ALDH) activity as key markers of the tumorigenic and drug-resistant CSC subpopulations in gastric cancer. This evidence concerns the gene CD44 and gastric cancer.